**DUE TO TECHNICAL DIFFICULTIES THESE ITEMS HAVE LOW AUDIO** 1. Call to Order. 2. Approval of Minutes from Aug. 16, 2013.
**DUE TO TECHNICAL DIFFICULTIES THE FIRST 10:51 OF THIS ITEM HAS LOW AUDIO LOW AUDIO** Cytokine and Cell-Adhesion Molecules Antagonists
Growth Hormone
Hypoglycemics, Incretin Enhancers/Mimetics
Therapeutic and Clinical Drug Reviews and Updates: Chris Andrews, Pharm.D., Magellan Medicaid Administration.
Pursuant to Texas Government Code, Chapter 531, and in accordance with Title 1,Texas Administrative Code, Part 15, Subchapter F, §354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Busin
6. Announcements of Drugs Recommended for the Medicaid PDL. 7. Adjourn.
Sep 20, 2013 Pharmaceutical and Therapeutic Committee
**DUE TO TECHNICAL DIFFICULTIES THESE ITEMS HAVE LOW AUDIO** 1. Call to Order. 2. Approval of Minutes from Aug. 16, 2013.
**DUE TO TECHNICAL DIFFICULTIES THE FIRST 10:51 OF THIS ITEM HAS LOW AUDIO LOW AUDIO** Cytokine and Cell-Adhesion Molecules Antagonists
Growth Hormone
Hypoglycemics, Incretin Enhancers/Mimetics
Therapeutic and Clinical Drug Reviews and Updates: Chris Andrews, Pharm.D., Magellan Medicaid Administration.
Pursuant to Texas Government Code, Chapter 531, and in accordance with Title 1,Texas Administrative Code, Part 15, Subchapter F, §354.1928, the Pharmaceutical and Therapeutics Committee may meet in Executive Session on one or more items listed under New Busin
6. Announcements of Drugs Recommended for the Medicaid PDL. 7. Adjourn.